NANOCORT Trademark

Trademark Overview


On Wednesday, April 9, 2014, a trademark application was filed for NANOCORT with the United States Patent and Trademark Office. The USPTO has given the NANOCORT trademark a serial number of 86247236. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 6, 2023. This trademark is owned by Enceladus Pharmaceuticals B.V.. The NANOCORT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary preparations for the treatment of inflammatory and immune disorders and conditions, namely, conditions of the bowel, kidneys, pancreas and liver, the group of vasculitis diseases, namely, Wegener's, Becet's, Kawasaki, Sle, transplant and allograft rejection, Graft versus Host disease (GvHD), arthritic and rheumatic diseases, multiple sclerosis, inflammatory bowel diseases and inflammatory conditions of the pancreas and liver, nephrology diseases, inflammatory conditions of the kidney, arteriovenous fistula failure, traumatic lesions, and for the treatment of cancer, all of the foregoing administered in hospitals by parenteral treatment; and all of the foregoing excluding any kind of product for the treatment of allergic rhinitis, and to the exclusion of anti-histamine products, respiratory products and any kind of product for the treatment of allergic rhinitis or respiratory conditions or diseases
nanocort

General Information


Serial Number86247236
Word MarkNANOCORT
Filing DateWednesday, April 9, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 6, 2023
Registration Number4980589
Registration DateTuesday, June 21, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 21, 2014

Trademark Statements


Goods and ServicesPharmaceutical and veterinary preparations for the treatment of inflammatory and immune disorders and conditions, namely, conditions of the bowel, kidneys, pancreas and liver, the group of vasculitis diseases, namely, Wegener's, Becet's, Kawasaki, Sle, transplant and allograft rejection, Graft versus Host disease (GvHD), arthritic and rheumatic diseases, multiple sclerosis, inflammatory bowel diseases and inflammatory conditions of the pancreas and liver, nephrology diseases, inflammatory conditions of the kidney, arteriovenous fistula failure, traumatic lesions, and for the treatment of cancer, all of the foregoing administered in hospitals by parenteral treatment; and all of the foregoing excluding any kind of product for the treatment of allergic rhinitis, and to the exclusion of anti-histamine products, respiratory products and any kind of product for the treatment of allergic rhinitis or respiratory conditions or diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEnceladus Pharmaceuticals B.V.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
Address1094 ND Amsterdam
NL

Party NameEnceladus Pharmaceuticals B.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address1094 ND Amsterdam
NL

Party NameEnceladus Pharmaceuticals B.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address1094 ND Amsterdam
NL

Trademark Events


Event DateEvent Description
Friday, January 6, 2023CANCELLED SEC. 8 (6-YR)
Monday, June 21, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 21, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, May 24, 2016REVIEW OF CORRESPONDENCE COMPLETE
Wednesday, March 2, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 20, 2015WITHDRAWN FROM ISSUE - EXAMINING ATTORNEY REQUEST
Thursday, November 19, 2015ELECTRONIC RECORD REVIEW COMPLETE
Friday, November 13, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 13, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 6, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 23, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 23, 2015NON-FINAL ACTION E-MAILED
Wednesday, September 23, 2015NON-FINAL ACTION WRITTEN
Thursday, September 10, 2015PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, May 15, 2015ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, May 5, 2015EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, April 29, 2015CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Monday, April 27, 2015ASSIGNED TO PETITION STAFF
Thursday, April 16, 2015TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, January 16, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 16, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 7, 2014EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, October 21, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 21, 2014PUBLISHED FOR OPPOSITION
Wednesday, October 1, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 15, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 15, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 9, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 9, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 27, 2014ASSIGNED TO LIE
Thursday, August 21, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 22, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 22, 2014NON-FINAL ACTION E-MAILED
Tuesday, July 22, 2014NON-FINAL ACTION WRITTEN
Thursday, July 17, 2014ASSIGNED TO EXAMINER
Monday, April 21, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 12, 2014NEW APPLICATION ENTERED